Legacy statistical computing environments can quietly become a major risk, slowing clinical timelines, increasing audit exposure, and limiting scale. That’s exactly the challenge a global biopharmaceutical company faced as its clinical portfolio grew.
To overcome fragmented systems, compliance gaps, and infrastructure limitations, the organization partnered with Axtria to modernize its Clinical Data Repository and Statistical Computing Environment (CDRSCE).
At a Glance
In just 12 months, the client transitioned from disconnected legacy platforms to a validated, enterprises cale CDRSCE, without disrupting ongoing studies.
The transformation included:
- Consolidation of clinical data into a single, governed repository
- Deployment of fully validated GxPcompliant environments
- Migration of 2,000+ clinical studies with full traceability
- Onboarding of 200+ users with room to scale
Why This Matters
Modern clinical development demands more than incremental fixes. It requires platforms that are audit ready by design, scalable for future growth, and easy for teams to adopt.
This case study shows how disciplined execution—across validation, migration, infrastructure, and program governance—can deliver measurable results within practical timelines.
Key Takeaways
- Compliance can be embedded, not bolted on
- Largescale migrations don’t have to disrupt active studies
- A single source of truth accelerates analysis and collaboration
- Strong program management is critical to platform success
Download the full case study to explore the approach, architecture, and execution model behind this transformation, and see how Axtria helps life sciences organizations modernize clinical data operations with confidence.
